Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jeremy Yuen Chun Teoh, Peter Ka Fung Chiu, Samson Yun Sang Chan, Darren Ming Chun Poon, Ho-Yuen Cheung, Simon See Ming Hou & Chi-Fai Ng. (2015) Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer. The Aging Male 18:3, pages 180-185.
Read now
Read now
Articles from other publishers (13)
Sakkarai Mohamed Asha Parveen, Karthik Reddy Kami Reddy & Ramesh Ummanni. (2023) Dimethylarginine Dimethylaminohydrolase - 1 expression is increased under tBHP-induced oxidative stress regulates nitric oxide production in PCa cells attenuates mitochondrial ROS-mediated apoptosis. Nitric Oxide 138-139, pages 70-84.
Crossref
Crossref
Valeriy Zub & Oleksandr Tolstanov. (2022) MEDICAL AND SOCIAL SUBSTANTIATION OF THE PROBLEM OF QUALITY OF LIFE OF PATIENTS WITH PROSTATE CANCER. Proceeding of the Shevchenko Scientific Society. Medical Sciences 69:2.
Crossref
Crossref
Shintaro Narita, Shingo Hatakeyama, Shinichi Sakamoto, Takuma Kato, Juichi Inokuchi, Yoshiyuki Matsui, Hiroshi Kitamura, Hiroyuki Nishiyama & Tomonori Habuchi. (2022) Management of prostate cancer in older patients. Japanese Journal of Clinical Oncology 52:6, pages 513-525.
Crossref
Crossref
Andrea Luciani, Cristina Falci, Fausto Petrelli & Giuseppe Colloca. 2022. Frailty in Older Adults with Cancer. Frailty in Older Adults with Cancer
357
370
.
Stéphane Droupy, Marie‐Hélène Colson, Nathalie Pello‐Leprince‐Ringuet, Valérie Perrot & Aurélien Descazeaud. (2021) EQUINOXE study: Impact of relational cohesion and sexuality on the quality of life of patients treated with gonadotropin‐releasing hormone agonist for prostate cancer. BJUI Compass 3:1, pages 45-54.
Crossref
Crossref
Meng Li, Hanmei Xu & Junzhi Wang. (2020) Optimized functional and structural design of dual-target LMRAP, a bifunctional fusion protein with a 25-amino-acid antitumor peptide and GnRH Fc fragment. Acta Pharmaceutica Sinica B 10:2, pages 262-275.
Crossref
Crossref
Thierry Lebret, Alain Ruffion, Igor Latorzeff, Marc Zerbib, Jean-Luc Moreau, Dominique Rossi, Nathalie Pello-Leprince-Ringuet, Valérie Perrot & Christophe Hennequin. (2018) Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapy. Therapeutic Advances in Urology 10:12, pages 365-376.
Crossref
Crossref
K. Hachi, K. Boualga, K. Chettibi, M. Harouni, M. Ounnoughene, N. Bekkat-Berkani, P. Maisonobe & M.J. Yousfi. (2018) Étude algérienne des effets bénéfiques de la triptoréline sur les symptômes du bas appareil urinaire chez les patients atteints d’un cancer de la prostate non localisé. Progrès en Urologie 28:8-9, pages 450-459.
Crossref
Crossref
Thierry Roumeguère, Joseph Sfeir, Elie El Rassy, Simone Albisinni, Pierre Van Antwerpen, Karim Zouaoui Boudjeltia, Nassim Farès, Joseph Kattan & Fouad Aoun. (2017) Oxidative stress and prostatic diseases. Molecular and Clinical Oncology 7:5, pages 723-728.
Crossref
Crossref
Axel S. Merseburger & Marie C. Hupe. (2016) An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer. Advances in Therapy 33:7, pages 1072-1093.
Crossref
Crossref
Xiaobo Zhong, Emerson A. Lim, Dawn L. Hershman, Carol M. Moinpour, Joseph Unger, Shing M. Lee, Xiaobo Zhong, Emerson A. Lim, Dawn L. Hershman, Carol M. Moinpour, Joseph Unger & Shing M. Lee. (2016) ReCAP: Identifying Severe Adverse Event Clusters Using the National Cancer Institute’s Common Terminology Criteria for Adverse Events. Journal of Oncology Practice 12:3, pages 245-246.
Crossref
Crossref
A. Eisenhardt, T. Schneider, K. Scheithe, C. Colling & A. Heidenreich. (2015) Lebensqualität von Patienten mit Prostatakarzinom unter Androgendeprivation mit GnRH-AnalogaQuality of life of patients with prostate cancer under androgen deprivation with GnRH analogues. Der Urologe 55:2, pages 176-183.
Crossref
Crossref
Maxim J. McKibben & Angela B. Smith. (2014) Evaluation and Management of the Geriatric Urologic Oncology Patient. Current Geriatrics Reports 4:1, pages 7-15.
Crossref
Crossref